Introduction {#s1}
============

Ribosome assembly is the most energy demanding process linked to cell growth and requires coordinated production of processed ribosomal RNAs (rRNAs), ribosomal proteins (RPs) and ribosome biogenesis (RiBi) factors. This massive biosynthetic program permits rapidly growing yeast cells to produce about 2000 ribosomes per minute ([@bib69]), which is critical for sustaining high rates of growth (mass accumulation) and proliferation. At the same time, though, ribosome assembly poses a constant threat to cellular protein homeostasis and continued growth, since it requires the coordinated and large-scale assembly of four rRNAs with 79 different RPs, the latter of which are known to be highly prone to aggregation ([@bib11]; [@bib50]; [@bib52]; [@bib70]). Indeed, unassembled RPs in metazoans have long been known to activate p53, through titration of its negative regulator MDM2, and conserved p53-independent pathways that respond to perturbations in ribosome assembly are now beginning to emerge ([@bib26]). Given the absence of p53 in yeasts, *Saccharomyces cerevisiae* is a promising model system in which to uncover ancestral processes that might monitor ribosome assembly to regulate growth and protein homeostasis in eukaryotes.

Heat shock factor 1 (Hsf1) is a central actor in Protein Quality Control (PQC) and protein homeostasis (proteostasis) in eukaryotes, in both stressed and unstressed cell, and in pathological situations ([@bib34]). Notably, Hsf1 is a direct modulator of tumorigenesis and becomes essential, as it is in budding yeast ([@bib60]), to support growth of malignant cells ([@bib57]). Hsf1 prevents protein aggregation and proteome imbalance by driving the expression of a small regulon including genes encoding essential chaperones (Hsp70/Hsp90), nuclear/cytoplasmic aggregases, and proteasome components ([@bib60]; [@bib39]; [@bib51]). Interestingly, studies in budding yeast reveal that the Ribosome Quality Control complex (RQC), conserved from yeast to human ([@bib4]), increases Hsf1 activity under conditions of translation stress. However, many essential aspects of Hsf1 regulation remain to be elucidated, in particular whether its transcriptional activity is linked to ribosome biogenesis itself. Recently, a conserved PQC mechanism referred to as Excess Ribosomal Protein Quality Control (ERISQ) was described that specifically recognizes unassembled RPs in the nucleus and targets them for proteasome degradation ([@bib61]; [@bib62]), thus illuminating observations made 40 years ago showing that excess RPs are rapidly degraded ([@bib21]; [@bib68]). Sung and colleagues showed that the ubiquitin ligase Tom1 plays an important role in ESRIQ by preventing the accumulation of detergent-insoluble RPs. The potential role of Hsf1 in ERISQ has not yet been explored.

Given the tremendous investment of cellular resources involved in ribosome production ([@bib69]) and the fact that a decrease of ribosome abundance protects cells against proteotoxic stress ([@bib23]; [@bib46]), it might be expected that cells have evolved mechanisms to rapidly decrease RP gene transcription in the face of defects in ribosome assembly, in order to both save energy and reestablish cellular proteostasis. In *S. cerevisiae*, RP gene transcription is known to be tightly regulated according to growth conditions through the stress-sensitive transcription factor (TF) Ifh1. Thus, Ifh1 is rapidly released from RP promoters only minutes following inhibition of the conserved eukaryotic growth regulator Target Of Rapamycin Complex 1 (TORC1) kinase ([@bib58]). Although it has been shown that Ifh1 promoter binding is coordinated with RNA polymerase I (RNAPI) activity upon prolonged TORC1 inhibition to help balance RP and rRNA production ([@bib1]; [@bib54]), how Ifh1 is removed from RP gene promoters to immediately downregulate their expression following stress remains a mystery. Furthermore, possible links between RP gene expression, ribosomal assembly and the protein homeostasis transcription program driven by Hsf1 remain important open questions.

In this study, we uncover a novel regulatory pathway, hereafter referred to as the Ribosomal Assembly Stress Response (RASTR), that allows rapid and simultaneous up-regulation of protein homeostasis genes and downregulation of RP genes following disruption of various steps in ribosome biogenesis (rRNA production, processing or RP assembly). We show that RASTR is highly specific to the RP and Hsf1 regulons, with little or no effect on a much larger group of genes implicated in the Environmental Stress Response (ESR). Importantly, RASTR requires neo-synthesis of RPs following stress and is linked to the accumulation of RP aggregates, which we propose lead to Hsf1 activation, through chaperone competition, and to the sequestration of Ifh1 in an insoluble nucleolar fraction. Notably, we show that protein synthesis inhabitation via cycloheximide treatment leads to a transcriptional response opposite to that of RASTR, supporting a model in which unstressed cells constantly monitor nuclear levels of unassembled RPs and use this information to balance expression of Hsf1 target genes with those encoding RPs. Finally, we demonstrate that RASTR is the initial transcriptional response to inactivation of TORC1 kinase, supporting a key role for this regulatory pathway in the activation of a protein homeostasis transcriptional program that allows cells to cope with the proteotoxic consequences of disruptions to ribosome biogenesis.

Results {#s2}
=======

Topoisomerase depletion triggers a rapid repression of RP genes and activation of proteostasis genes {#s2-1}
----------------------------------------------------------------------------------------------------

In an effort to better understand the role of the two major eukaryotic DNA topoisomerases in protein-coding gene transcription, we generated yeast strains in which Top1, Top2, or both of these enzymes are rapidly degraded by the auxin-induced degron (AID) method ([@bib48]) and confirmed by western blotting that significant depletion of either protein was obtained between 10 and 20 min following auxin addition to the medium, and that Top2 depletion, as expected, prevents cell growth ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). We then performed ChIP-seq analysis of RNA polymerase II (RNAPII) in the Top1-AID, Top2-AID and Top1/2-AID strains at 20 and 60 min following auxin addition ([Figure 1A--C](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). As expected ([@bib5]; [@bib6]), the absence of Top2 had little or no effect on RNAPII distribution ([Figure 1B](#fig1){ref-type="fig"}). However, Top1 depletion triggered a rapid response at two specific groups of genes: upregulation of Hsf1 target genes and downregulation of RP genes ([Figure 1A,D](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1C,D](#fig1s1){ref-type="fig"}). Remarkably, this response was transient, as both groups of genes returned to normal levels (i.e. before auxin addition) by 60 min. This re-equilibration was dependent upon Top2 since it failed to occur in the Top1/2-AID strain, where prolonged auxin treatment led to significant dysregulation of many other RNAPII-transcribed genes ([Figure 1C](#fig1){ref-type="fig"}).

![Rapid degradation of Topoisomerase 1 (Top1) induces a transient induction of Heat Shock Factor 1 (Hsf1) target genes and down-regulation of ribosomal protein (RP) genes.\
(**A, B, C**) Scatter plots (top panels) and box plots (bottom panels) comparing RNAPII binding (as measured by Rpb1 ChIP-seq) in Top1-AID (**A**), Top2-AID (**B**) and Top1/2-AID (**C**) strains at the indicated times following either auxin or vehicle addition to the media. Indicated gene categories (RP, n = 138; ribosome biogenesis \[RiBi\], n = 229; Msn2 target genes, n = 45; and Hsf1 target genes, n = 19) are color-coded on the scatter plots and displayed separately on the box plots, together with all remaining genes as a fifth class (others, n = 4610). (**D**) Genome browser tracks showing RNAPII (Rpb1) ChIP-seq read counts at the indicated positions on chromosomes X, XIII and VII at 0, 20, or 60 min following auxin addition to Top1-AID (top panels) and Top1/2-AID (bottom panel) strains. Gene names and open reading frame (ORF) positions are shown above. (**E**) Ifh1 occupancy, measured by qPCR ChIP at the *RPL30* and *RPL39* promoters 20 min following auxin addition to cultures of Top1-AID and Top1/2-AID strains. Bar height indicates the average and error bars the range of n = 4 biological replicates. (**F**) Schematic representation of protocol for Hsf1-FRB nuclear depletion (anchor-away) induced by rapamycin (Rapa) followed by Top1-AID depletion. (**G**) Box plots showing RNAPII (Rpb1) ChIP-seq signal following Hsf1-FRB nuclear depletion by anchor-away (-Hsf1, left panel), Top1-AID degradation (auxin, middle panel) or both Hsf1-FRB and Top1-AID depletion (auxin / -Hsf1, right panel) for the five functional groups described in (**A**).](elife-45002-fig1){#fig1}

Since upregulation of proteostasis-related genes and downregulation of RP genes are characteristic of many different stress responses, we decided to quantify the effect of Top1 depletion on transcription all gene groups that have been classified as part of the general 'Environmental Stress Response' (ESR; [@bib19]), which include an additional group of stress-induced genes regulated by the Msn2/4 TFs and a large suite of genes involved in ribosome biogenesis (RiBi genes). This analysis shows clearly that Top1 depletion, as well as depletion of both Top1 and Top2 (at the early 20 min time point), triggers a highly specific stress response linked to RP genes and Hsf1 target genes ([Figure 1A--C](#fig1){ref-type="fig"}). Such a targeted response is unlikely to result from a global topological effect on RNAPII recruitment but would instead appear to be the consequence of the activation of a specific signaling pathway that is more restricted in nature than the ESR.

To explore the target(s) of this hypothetical signaling pathway at RP genes, we monitored by qPCR ChIP the promoter association of three TFs (Rap1, Fhl1 and Ifh1) that operate at the majority (\>90%) of these 138 genes ([@bib28]). Interestingly, we found that the activator Ifh1 is rapidly released from RP gene promoters after topoisomerases depletion ([Figure 1E](#fig1){ref-type="fig"}), whereas Rap1 and Fhl1, which bind directly to RP promoter DNA, are not affected ([Figure 1---figure supplement 1E--F](#fig1s1){ref-type="fig"}). To confirm that Hsf1 is indeed required for upregulation of genes following Top1 depletion, we used the anchor-away technique ([@bib24]) to rapidly remove Hsf1 from the nucleus (30 min treatment with rapamycin; [@bib60]) before initiating Top1-AID degradation by auxin addition ([Figure 1F](#fig1){ref-type="fig"}). Efficient nuclear depletion of Hsf1 was confirmed by the inability of the Hsf1-FRB, Top1-AID strain to form colonies in the presence of rapamycin ([Figure 1---figure supplement 1G](#fig1s1){ref-type="fig"}). Note that the strain used in this and all other anchor-away experiments contains the *TOR1-1* mutation and is thus resistant to the normal physiological consequences of rapamycin treatment, which inactivates the growth-promoting TORC1 kinase ([@bib25]; [@bib37]). This experiment revealed that Hsf1 nuclear depletion completely abolishes activation of stress genes following Top1 depletion without affecting down-regulation of RP genes ([Figure 1G](#fig1){ref-type="fig"}). Therefore, activation of stress-induced genes following Top1 depletion is completely Hsf1-dependent, whereas repression of RP genes is independent of Hsf1 or the induction of its target genes. We would also note that the stress pathway induced by Top1 depletion is unusually restricted in comparison to many other stress responses that are often grouped together as the Environmental Stress Response (ESR; [@bib19]), since Msn2/4 target genes are not induced and RiBi genes are not downregulated ([Figure 1A,G](#fig1){ref-type="fig"}).

Top1 depletion arrests ribosome biogenesis and activates a ribosomal assembly stress response {#s2-2}
---------------------------------------------------------------------------------------------

Although it may seem surprising that depletion of topoisomerases can induce a Hsf1-dependent stress response, formation of distinct nuclear foci by the Btn2 aggregase and perinuclear accumulation of the proteasome subunit Pre6 following Top1/2 degradation ([Figure 2---figure supplement 1A,B](#fig2s1){ref-type="fig"}) both point to the induction of proteotoxic stress in the nucleus ([@bib44]). Top1 was initially identified through a mutation (*mak1*) defective in large ribosomal subunit production ([@bib63]) and was later shown to be required for proper rRNA synthesis ([@bib5]; [@bib15]; [@bib17]). Consistent with these findings, we observed a strong reduction of pre-rRNA synthesis as shown by decreased \[^3^H\]-adenine pulse-labeling of the RNAPI-transcribed 35S pre-rRNA, and two co-transcriptionally cleaved products, 27S and 20S pre-rRNAs, as early as 10 min after initiation of Top1 (or Top1 and Top2) depletion by addition of auxin to the medium ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). This decreased rRNA synthesis is accompanied by an elongation defect, as shown by the accumulation of truncated pre-rRNAs that were initially described by the Tollervey laboratory ([@bib15]; [Figure 2A](#fig2){ref-type="fig"}). Further downstream, the rapid defect in rRNA production caused by inhibition of RNAPI elongation leads to unbalanced production of 40S and 60S ribosomal subunits, with a marked deficiency of the large (60S) subunit relative to the small (40S) subunit ([Figure 2B](#fig2){ref-type="fig"}). This would be expected to create a disequilibrium between RP and rRNA production, and more specifically an excess of unassembled RPs. Consistent with this, we detect accumulation of both and large and small subunit proteins (Rpl3 and Rps8, respectively) in trailing fractions of polysome gradients ([Figure 2C](#fig2){ref-type="fig"}). These observations strongly suggest that RPs fail to be incorporated normally into ribosomes immediately following topoisomerase degradation. In addition, this sedimentation profile may also reflect the presence of disassembling or incompletely assembled pre-60S particles. RPs are known to be prone to aggregation ([@bib11]; [@bib50]; [@bib52]; [@bib70]) and recent reports show that newly synthetized, unassembled RPs accumulate in aggregates in response to ribosome assembly stress ([@bib61]; [@bib62]). Significantly, we also observed accumulation of RPs in an insoluble fraction following topoisomerase degradation ([Figure 2D](#fig2){ref-type="fig"}).

![The effects of Top1 depletion on RNAPII regulation are linked to an underlying defect in ribosome biogenesis.\
(**A**) Northern blot of 5'ETS1-containing rRNAs prepared from cultures of wild-type, Top1-AID, Top2-AID and Top1/2-AID cells that had been pulse-labeled for 2 min with \[^3^H\] adenine at the indicated times following addition of auxin to the media. Total RNAs were extracted and samples were separated on agarose gels, transferred to a nylon membrane and first directly autoradiographed to reveal pulse labeling of nascent rRNAs (see [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). The membrane was next hybridized with a ^32^P-labeled oligonucleotide probe allowing detection of all species containing 5'ETS1 (ACGACAAGCCT-ACTCGAATTCGT). Truncated pre-rRNA fragments, first identified in cells lacking Top1 ([@bib15]), are indicated (\*). (**B**) Polysome sedimentation profiles (OD~260~) of WT, Top1-AID, Top2-AID, and Top1/2-AID strains 20 min following auxin treatment (large panels, as indicated). The top of each gradient (fractions 7 to 11), corresponding to 40S and 60S subunit peaks, is expanded below, where peak height differences (60S:40S ratio) are indicated. (**C**) Total cell extracts prepared from the indicated fractions of sedimentation profiles of WT and Top1/2-AID strains (from B) were TCA precipitated and analyzed by Western blot following SDS-PAGE, using an antibody against Rpl3 and Rps8, as indicated. (**D**) Total (left panels) and detergent-insoluble pellet (right panels) fractions isolated from lysates of Top1/2AID cells treated (+) or not (-) with auxin were analyzed by SDS-PAGE and Coomassie blue staining (top panels) or immunoblotting with the indicated antibodies (bottom panels). The pellet fraction is overloaded 25-fold compared to the total extract fractions. (**E, F, G**) Scatter plots (top panels) comparing RNAPII (Rpb1) ChIP-Seq read counts for individual genes in Utp8-AID (**E**) or Utp13-AID (**F**) cells after 20 min of auxin or vehicle treatment, or WT cells after 20 min of treatment with diazaborine or vehicle (**G**) (y-axis: auxin or diazaborine) for 20 min versus non-depleted cells (x-axis, Vehicle). Each dot represents a gene (5041 genes in total) and genes are color-coded according to functional groups, as in [Figure 1A](#fig1){ref-type="fig"}. Bottom panels display the corresponding box plots for the four indicated gene categories plus all other genes (others).](elife-45002-fig2){#fig2}

The observations described above led us to hypothesize that the transcriptional response to Top1 degradation is a consequence of defective ribosome assembly, perhaps driven by the proteotoxic stress caused by the accumulation of unassembled RPs. To challenge this idea, we measured the transcriptional response to three different perturbations to ribosome biogenesis: depletion of two essential ribosome assembly factors (Utp8 and Utp13) and treatment of cells with diazaborine. Utp8p is a member of the t-UTP subcomplex of 90S pre-ribosomes and its depletion inhibits rDNA transcription, leading to a reduction of the primary 35S pre-rRNA transcript and subsequent processing intermediates ([@bib18]). In contrast, depletion of Utp13 (a member of the UTP-B subcomplex) interferes with downstream processing and synthesis of 40S subunits and causes decreased 18S rRNA levels without affecting the levels of the 25S or 5.8S rRNAs ([@bib18]). Diazaborine, an inhibitor of the essential Drg1 AAA-ATPase, rapidly blocks mid-late steps of 60S subunit maturation ([@bib38]). Remarkably, all these treatments triggered a similar transcriptional response to that which occurs following Top1 depletion, namely a specific downregulation of RP genes and upregulation of Hsf1 target genes ([Figure 2E--G](#fig2){ref-type="fig"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"}), which we refer to as the 'Ribosome Assembly STress Response' (RASTR).

Hsf1 activity is stimulated by many different types of cellular stress, including stalled ribosomes. A pioneering study reported that a set of proteins termed the RQC binds to 60S ribosomal subunits containing stalled polypeptides and leads to their degradation. In the process, the RQC triggers a specific stress signal that leads to Hsf1 target gene activation ([@bib4]). Thus, cells lacking a component of the RQC, the Tae2 protein, fail to activate Hsf1 following translational stress. To ask if RASTR might be related to the RQC, we induced Top1/2 degradation in *tae2-*Δ cells. We found that activation of two Hsf1 target genes (*SSA1* and *HSP42*) and downregulation of two RP genes (*RPL30* and *RPL39*) was unaffected by deletion of *TAE2* ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}) and conclude that RQC does not play a role in RASTR. These results highlight that cells have developed distinct mechanisms to adapt the Hsf1 transcriptional program to defects in both ribosome activity and ribosome assembly.

Ifh1 sequestration in an insoluble nuclear fraction during RASTR is driven by RP accumulation {#s2-3}
---------------------------------------------------------------------------------------------

Although many studies would support the notion that Hsf1 activation during RASTR occurs through sequestration of its inhibitory partner Hsp70 by RP aggregates ([@bib31]; [@bib59]; [@bib71]), it is less clear how ribosome assembly stress could trigger release of Ifh1 from RP gene promoters. We reported previously that the association of Ifh1 with RP gene promoters in growing cells is rapidly disrupted (within 5 min) following inhibition of the growth-promoting TORC1 kinase by addition of rapamycin to the medium ([@bib58]). More recently ([@bib1]), we found that stable release of Ifh1 from RP gene promoters (measured 20 min after rapamycin addition) requires its C-terminal domain together with a complex of proteins containing casein kinase 2 (CK2) and two RiBi factors, Utp22 and Rrp7, with which Ifh1 interacts to form the CURI complex ([@bib54]). Thus, in *ifh1-*ΔC cells the truncated protein is rapidly released but later returns to RP gene promoters following TORC1 inhibition. This led us to propose two distinct mechanisms controlling the promoter release of Ifh1 following stress: one operating at a short timescale (\<5 min) and the other on a long timescale (\~20 min). Interestingly, ifh1-ΔC promoter release is stable following Top1 depletion, suggesting that an unknown mechanism regulates Ifh1 during RASTR ([Figure 3A](#fig3){ref-type="fig"}).

![Evidence that Ifh1 is rapidly removed from RP gene promoters and sequestered in an insoluble nucleolar fraction pursuant to unassembled RP accumulation following RASTR initiation.\
(**A**) Ifh1 occupancy at the *RPL30* and *RPL37A* promoters 20 min following vehicle, rapamycin or auxin treatment of Top1/2-AID strains expressing either WT Ifh1 (*IFH1*) or a C-terminal truncated allele (*ifh1-∆C*). Bar height indicates the average and error bars the range of N = 4 biological replicates. (**B**) Box plots showing the kinetics of RNAPII ChIP-seq changes at Hsf1 target and RP genes at the indicated time points (minutes) following auxin treatment in Top1/2-AID (top panel) or Top1-AID (bottom panel) strains. (**C**) A Top1/2-AID strain expressing Ifh1-eGFP and Nhp6-mCherry was grown exponentially and cell samples were used for fluorescence microscopy analysis after 20 min of auxin (Aux) or vehicle (Veh) treatment. (**D**) *TOM1* (top panels) and *tom1-Δ* (bottom panels) strains expressing Ifh1-eGFP and Nhp6-mCherry were grown exponentially and cell samples were used for fluorescence or transmission microscopy analysis, as indicated. (**E**) Tenfold serial dilutions of *IFH1*, *ifh1-AA* (*ifh1 680A/681A*) or *ifh1-6* cells transformed in either *TOM1* or *tom1-Δ* backgrounds (as indicated) were grown in YPD medium for 44 hr at 30°C before being photographed. (**F**) Scatter plot comparing average number of peptides purified in an insoluble fraction from Top1/2-AID cells treated for 20 min with either auxin (y-axis, Auxin) or vehicle (x-axis, Vehicle). Each dot represents a protein, color-coded according to functional group as above (green: RP, red: Hsf1 target gene product, yellow: RiBi protein, gray: others), with some specific proteins indicated by arrows. (**G**) Gene Ontology and p-values of protein groups that are the most enriched in the insoluble fraction following Top1/2-AID depletion (Δ \> 3 peptides in insoluble fraction after topoisomerase depletion compared to vehicle in all experiments, n = 3 biological replicates).](elife-45002-fig3){#fig3}

The fact that RP gene repression and Hsf1 target gene activation occur with identical kinetics following RASTR activation ([Figure 3B](#fig3){ref-type="fig"}), and that Ifh1 concentrates in nuclear foci rapidly after topoisomerase depletion ([Figure 3C](#fig3){ref-type="fig"}), suggests that Ifh1 could be sensitive to the accumulation of unassembled RPs in the nucleus, as is presumably the case for Hsf1. Several lines of evidence are consistent with this hypothesis. To begin with, in cells lacking Tom1, an E3 ligase required for degradation of unassembled RPs ([@bib61]; [@bib62]), but not in *TOM1* cells, Ifh1 accumulates in prominent nuclear foci even in the absence of stress ([Figure 3D](#fig3){ref-type="fig"}). This suggests that Ifh1 aggregates in cells that are unable to efficiently degrade excess RPs, even under optimal growth conditions. Consistent with this, the published mass spectrometry data of insoluble fractions from cells either treated with the proteasome inhibitor bortezomib or lacking Tom1 clearly identified Ifh1, together with RPs, RiBi proteins and two Hsp70 proteins, Ssa1 and Ssa2, inhibitory partners of Hsf1 ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). These data indicate that Ifh1 could be trapped in an insoluble cellular fraction in the absence of Tom1 and thus decrease the pool of Ifh1 able to bind with RP gene promoters. To test this possibility, we combined deletion of *TOM1* with a mutant allele of *IFH1* (*ifh1-AA*) that weakens its interaction with RP gene promoters. Remarkably, *tom1-*Δ is synthetically lethal with *ifh1-AA* ([Figure 3E](#fig3){ref-type="fig"}) supporting the notion that RP aggregation could directly impact on Ifh1 promoter binding. Lastly, to exclude the possibility that the genetic interaction between *TOM1* and the mutated allele of *IFH1* could be linked to the growth defect of this mutation, we examined another mutated allele of IFH1 (*ifh1-6*) that triggers a similar growth defect ([Figure 3E](#fig3){ref-type="fig"}). Importantly, we showed in a previous study that this *ifh1-6* mutant protein remains bound at high levels to RP genes promoter even under stress conditions ([@bib1]). Remarkably, *tom1-Δ* is not synthetically lethal with *ifh1-6* ([Figure 3E](#fig3){ref-type="fig"}), supporting the notion that genetic interaction with *ifh1-AA* is directly linked to the ability of Ifh1 to bind RP gene promoters.

To assess directly whether Ifh1 is sequestered in aggregates during RASTR, we analyzed by mass spectrometry the insoluble fraction following topoisomerase depletion. As previously reported for *tom1-*Δ cells ([@bib61]), the insoluble fraction is enriched in chaperones and RPs ([Figure 3F,G](#fig3){ref-type="fig"}). We also noted a strong increase in RiBi factors, primarily those implicated in biogenesis of the large ribosomal subunit ([Figure 3G](#fig3){ref-type="fig"}). Importantly, Ifh1 was never detected in an insoluble fraction in the absence of stress but was invariably detected in these fractions following topoisomerase depletion ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). This rapid sequestration of Ifh1 may be sufficient to explain the observed downregulation of RP genes during RASTR.

Neo-synthetized RPs are required for RASTR activation {#s2-4}
-----------------------------------------------------

Given their fast turnover rate, nuclear accumulation in the absence of ribosome assembly and propensity to aggregate, unassembled RPs could be ideally positioned to rapidly signal ribosome biogenesis defects ([@bib61]; [@bib43]). To evaluate the importance of newly synthetized RPs in RASTR, we blocked their production by cytoplasmic anchoring of Ifh1 before topoisomerase depletion ([Figure 4A](#fig4){ref-type="fig"}). It is important to note that Ifh1 binding is highly specific to RP genes ([@bib28]) and that the transcriptional effect of its nuclear depletion is restricted to RP genes and a very small number of additional targets ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Although Ifh1 depletion by anchor-away may not be complete (the strain still grows on plates containing rapamycin, albeit slowly, even though Ifh1 is essential for growth; [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), it nonetheless leads to a significant and highly specific decrease in RP gene transcription as measured by RNAPII ChIP-seq ([Figure 4B](#fig4){ref-type="fig"}; [Supplementary file 4](#supp4){ref-type="supplementary-material"}). Interestingly, Ifh1 depletion also leads to aberrant rRNA processing ([Figure 4C](#fig4){ref-type="fig"}) as would expected in conditions where RP levels become limiting ([@bib53]). Remarkably, we noted that 60 min of Ifh1 anchoring alone, in the absence of topoisomerase depletion, also caused a significant down-regulation of Hsf1 target genes ([Figure 4D](#fig4){ref-type="fig"}; [Supplementary file 4](#supp4){ref-type="supplementary-material"}) even though Ifh1 is absent from the promoters of these genes ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}), suggesting that the Hsf1 transcriptional program is continuously influenced by RP production. Consistent with this idea, we found that upregulation of Hsf1 target genes was either abolished or strongly reduced ([Figure 4E,F,G](#fig4){ref-type="fig"}; [Supplementary file 4](#supp4){ref-type="supplementary-material"}) when Top1 or Top1 and Top2 were degraded following nuclear depletion of Ifh1, indicating that RP production is required for Hsf1 target gene activation during RASTR.

![Downregulation of RP gene expression by Ifh1 nuclear depletion prior to RASTR initiation strongly dampens Hsf1 target gene activation.\
(**A**) Schematic of protocol for Ifh1-FRB nuclear depletion (0--60 min of rapamycin treatment) followed by Top1-AID or Top1/2-AID degradation (auxin treatment, 40--60 min). (**B**) Scatter plot comparing RNAPII (Rpb1) ChIP-seq in Ifh1-FRB cells either rapamycin-treated for 60 min (y-axis, -Ifh1, Ifh1-FRB nuclear depletion) or untreated (x-axis, Vehicle, no Ifh1-FRB depletion). Categorization and color coding of genes as above. (**C**) Northern blots of pre-rRNA after 0 or 60 min of Ifh1-FRB nuclear depletion by anchor-away (-Ifh1) or vehicle (Veh) treatment of Ifh1-FRB strain. (**D**) Box plots of the data shown in (**B**) for the indicated five gene categories, showing fold-change upon Ifh1-FRB nuclear depletion compared to mock-treated cells. (**E**) Scatter plots comparing RNAPII (Rpb1) ChIP-seq in Top1-AID Ifh1-FRB cells either auxin-treated (y-axis, Aux, left panel) or auxin- plus rapamycin-treated (y-axis, Aux / -Ifh1, right panel) treated, as described in (**A**), versus untreated cells (x-axis, vehicle, both panels). (**F**) As in (**E**), but for Top1/2-AID Ifh1-FRB cells. (**G**) Box plots showing RNAPII (Rpb1) ChIP-seq change after rapamycin and/or auxin treatment for Hsf1 target genes in Top1-AID Ifh1-FRB cells (left) or Top1/2-AID Ifh1-FRB cells (right). Asterisks show significant difference according to student's t-test (\*: p\<0.05, \*\*\*: p\<0.001, ns: Not significant), p-value is indicated.](elife-45002-fig4){#fig4}

Cells balance RP production and Hsf1 activity even in the absence of stress {#s2-5}
---------------------------------------------------------------------------

As an alternative approach to test the requirement for de novo RP synthesis to initiate RASTR we used cycloheximide treatment, which blocks all translational elongations, thus leading to rapid depletion of the nuclear pools of RPs ([Figure 5A](#fig5){ref-type="fig"}; [@bib21]; [@bib68]; [@bib53]; [@bib33]). As reported by others ([@bib53]), we confirmed that cycloheximide alone also triggers a rapid arrest of rRNA processing ([Figure 5B](#fig5){ref-type="fig"}). Quite strikingly, we observed a transcriptional response to cycloheximide treatment exactly opposite to that induced by RASTR, namely Hsf1 target gene downregulation and RP gene upregulation ([Figure 5C](#fig5){ref-type="fig"}; [Supplementary file 5](#supp5){ref-type="supplementary-material"}). This finding suggests that even in unstressed cells RP production may contribute to a basal level of Hsf1 activation while at the same time limiting Ifh1 activity at RP gene promoters.

![Cycloheximide treatment induces a rapid RNAPII transcriptional response opposite and epistatic to that of RASTR.\
(**A**) Schematic related to experiments in subsequent panels describing the effect of cycloheximide treatment on de novo RP production and auxin treatment on Top1-AID (or Top1/2-AID) degradation. (**B**) Northern blots of pre-rRNA after 0, 5, 10, and 20 min of cycloheximide (CHX) treatment. (**C**) Scatter plot comparing RNAPII (Rpb1) ChIP-seq after 20 min of cycloheximide treatment (y-axis, CHX) to that of non-treated cells (x-axis, vehicle) at the indicated groups of target genes. (**D**) Scatter plots comparing RNAPII ChIP-seq in auxin-treated to untreated cells (left panel) and in auxin + cycloheximide (CHX)-treated to untreated cells (right panel). In both cases cells express Top1-AID. (**E**) Scatter plots comparing RNAPII ChIP-seq as in (**D**), but for Top1/2-AID cells. (**F**) Box plots showing RNAPII ChIP-seq fold-change for Hsf1 target genes after cycloheximide (CHX) and/or auxin (Aux) treatment of Top1-AID or Top1/2-AID cells, as indicated (data taken from experiments shown in **D** and **E**). p-Values are shown above the indicated comparisons together with significance according to student's t-test (\*\*\*: p\<0.001, ns: not significant). (**G--H**) Top1/2-AID strains expressing Rpl25-eGFP (**G**) or Ifh1-eGFP (**H**) and Nhp6-mCherry were grown exponentially and samples were used for fluorescence microscopy analysis after 20 min of auxin (top) or vehicle treatment (bottom), in the absence (left) or presence (right) of cycloheximide (CHX).](elife-45002-fig5){#fig5}

Significantly, treatment of cells undergoing Top1 or Top1/2 depletion with cycloheximide (auxin + CHX) completely abolished both RP gene repression and activation of Hsf1 target genes ([Figure 5D,E](#fig5){ref-type="fig"}; [Supplementary file 5](#supp5){ref-type="supplementary-material"}). Indeed, Hsf1 target gene activation under these conditions is lower than in untreated cells and not significantly different than that seen in cells treated with cycloheximide alone ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). These findings clearly demonstrate that RASTR is dependent upon de novo protein synthesis. Importantly, it was recently reported that cycloheximide treatment efficiently prevents aggregation of newly synthesized RPs following proteasome inhibition ([@bib61]). Perhaps as a direct consequence of this, we found that CHX treatment also leads to strong reduction of Ifh1-eGFP nuclear foci that are observed in cells lacking the ubiquitin ligase Tom1, which is specifically required for efficient degradation of unassembled RPs ([@bib61]; [@bib62]; [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Furthermore, Ifh1 dis-aggregation following cycloheximide exposure is associated with increased Ifh1 binding at a RP gene promoter, which becomes significant in *tom1*-Δ cells ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Similarly, cycloheximide treatment also prevents the release of Ifh1 from RP gene promoters in response to the activation of RASTR by topoisomerase depletion ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). Considered as a whole, these data suggest that both RP and Ifh1 subnuclear structures (aggregates) are dynamic, promoted by de novo RP production upon RASTR initiation, and capable of influencing Ifh1 promoter binding. Consistent with this view, we observed a large increase in cells that accumulate RP (Rpl25) or Ifh1 nuclear aggregates during RASTR that is abolished in the presence of cycloheximide ([Figure 5F,G](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1E, F](#fig5s1){ref-type="fig"}).

Taken together with the strong reduction of Hsf1 target gene activation following Ifh1 cytoplasmic anchoring, both in the presence and absence of topoisomerase degradation, our observations on the effect of cycloheximide highlight the interwoven nature of RP and Hsf1 target gene regulons and support the notion that unassembled, aggregated RPs constitute the primary RASTR-induced signal capable of regulating both Ifh1 and Hsf1 activities, albeit in an opposite direction. More generally, these data indicate that newly synthetized RPs, in both stressed and unstressed cells, operate as a central hub in coordinating the expression of RP genes themselves with the Hsf1-dependent activation of chaperone and proteasome genes.

RASTR is the first transcriptional response to environmental stress {#s2-6}
-------------------------------------------------------------------

We next turned our attention to the potential involvement of RASTR during more general stress responses that might also rapidly affect ribosome assembly. In an initial set of experiments, we inactivated the conserved growth-promoting TORC1 kinase by treatment of cells with rapamycin, which is known to mimic a major part of the environmental stress response, including osmotic and redox stress, as well as carbon, nitrogen, phosphate or amino acid starvation ([@bib37]). As reported previously, rapamycin triggers a rapid arrest of rRNA processing ([Figure 6A](#fig6){ref-type="fig"}) and a decrease of RP and RiBi gene expression ([Figure 6B,C](#fig6){ref-type="fig"}; [Supplementary file 6](#supp6){ref-type="supplementary-material"}). Interestingly, we noted that Hsf1 target genes are transiently up- and downregulated at 5 and 20 min, respectively, following rapamycin addition ([Figure 6B,C](#fig6){ref-type="fig"}; [Supplementary file 6](#supp6){ref-type="supplementary-material"}), suggesting that RASTR is activated at the early time point but shortly thereafter turned off. Consistent with this view, it has been reported that RP production ceases around 15 min after rapamycin treatment ([@bib53]), which we suggest would turn off the signal for RASTR, thus explaining the downregulation of Hsf1 target genes observed at 20 min.

![RASTR comprises the cycloheximide-sensitive component of the early RNAPII response to TORC1 inhibition.\
(**A**) Northern blots of pre-rRNA from wild type cells after 5 or 30 min of vehicle (Veh) or rapamycin (Rap) treatment. (**B**) Scatter plots comparing RNAPII (Rpb1) ChIP-seq in cells after 5 (y-axis, left panel) or 20 min (y-axis, right panel) of rapamycin (Rap) treatment to non-treated cells (x-axis, vehicle). Gene groups are color-coded as indicated. (**C**) Genome browser tracks showing RNAPII ChIP-seq read counts for three consecutive RP genes on chromosome X (in green, left panel) or at the *SSA1* gene on chromosome I (in red, right panel), following 0, 5, or 20 min (top, middle, bottom panels, respectively) of rapamycin treatment. Gene annotations (gene name, open reading frame and direction of transcription) are shown above the tracks. (**D**) Scatter plots comparing RNAPII ChIP-seq in cells pre-treated with cycloheximide (CHX) then treated for 5 (left panel) or 20 (right panel) minutes with rapamycin to cells untreated (x-axis, vehicle). Schematic representation of the experimental protocols is shown below each panel. Cells were collected for RNAPII ChIP-seq analysis after 5 (left panel) or 20 min (right panel) of rapamycin treatment. (**E**) Ifh1 occupancy at the *RPL30* and *RPL37A* promoters following 5 or 20 min of rapamycin treatment (Rap) in cells pre-treated or not with cycloheximide (CHX) for 5 min. Bar height indicates the average and error bars the range of N = 4 biological replicates.](elife-45002-fig6){#fig6}

To explore this hypothesis further, we took advantage of our observation that cycloheximide treatment prevents RASTR activation by either Top1 or Top1/2 degradation ([Figure 5](#fig5){ref-type="fig"}) and treated cells with cycloheximide 5 min before rapamycin addition of either 5 or 20 min ([Figure 6D](#fig6){ref-type="fig"}, see schematics of experimental protocols below the respective panels). Remarkably, this specifically prevented RP gene repression and Hsf1 target gene activation at 5 min following rapamycin addition, whereas at the longer time point (20 min) RP genes and Hsf1 were regulated independently of cycloheximide ([Figure 6D,E](#fig6){ref-type="fig"}; [Supplementary file 6](#supp6){ref-type="supplementary-material"}). Consistent with the early block in RP gene downregulation being due to a failure to initiate RASTR immediately following rapamycin addition, we showed that cycloheximide pre-treatment prevents release of Ifh1 from RP gene promoters at 5 min, but not at 20 min following rapamycin treatment ([Figure 6F](#fig6){ref-type="fig"}).

The effects of rapamycin treatment described above are fully consistent with our previous report demonstrating that regulation of RP gene transcription following TORC1 inactivation by rapamycin operates through two distinct mechanisms at short and long timescales, with the latter dependent on RNAPI activity and the CURI complex ([@bib1]). The short timescale mechanism described here, which is dependent upon continued protein synthesis and presumably mediated by RASTR, allows cells to rapidly arrest RP production and avoid or minimize proteotoxic stress induced by arrested ribosome assembly. The second mechanism permits the resumption of RP production only when rRNA synthesis also resumes ([@bib1]). These two mechanisms could be particularly useful to rapidly adapt ribosome production to new growth conditions.

To explore the possible generality of rapid RASTR-mediated shut-down of RP gene transcription in response to stress, we measured the transcriptional response to heat shock, which is known to transiently downregulate both RP gene and rRNA transcription ([@bib19]; [@bib30]). As expected, we observed strong downregulation of RP genes and upregulation of Hsf1 target genes only 5 min following a shift in temperature to 40°C ([Figure 7A--C](#fig7){ref-type="fig"}, left panels) that was also accompanied by strong upregulation of Msn2 target genes and downregulation of RiBi genes ([Figure 7A](#fig7){ref-type="fig"}, left panel). The heat-shock transcriptional response is thus much broader than that to ribosome assembly stress, despite their common effects on RP and Hsf1 target gene expression. Remarkably, though, we found that cycloheximide pre-treatment prevents the strong and immediate repression of RP genes following heat shock ([Figure 7A,B](#fig7){ref-type="fig"}; right panels; [Supplementary file 6](#supp6){ref-type="supplementary-material"}), consistent again with the idea that this facet of the heat-shock response is identical to that which occurs during RASTR. Importantly though, Hsf1 target genes are still activated following heat shock in the presence of cycloheximide ([Figure 7A,C](#fig7){ref-type="fig"}; right panels), presumably because the unfolding of thermo-labile proteins induced by heat shock is alone sufficient to activate Hsf1 even in the absence of continuing RP synthesis. Nevertheless, the striking requirement for de novo protein synthesis for RP gene downregulation following heat shock strongly suggests that RASTR plays an integral role in this component of the heat-shock response and thus may constitute the earliest transcriptional response, at the level of RNAPII, to a wide variety of stress conditions.

![RP gene downregulation following heat shock is blocked by cycloheximide.\
(**A**) Scatter plots comparing RNAPII ChIP-Seq in cells pre-treated or not with cycloheximide (CHX) followed by 5 min of heat shock (y-axis, HS) versus non-stressed cells (x-axis, no HS, no CHX). Schematic of the protocol for each experiment is shown below the data panels: mock pre-treatment (vehicle; 0--5 min) followed by heat shock (HS; 40°C, 5--10 min; left panel) or cycloheximide (CHX) pre-treatment (0--5 min) followed by heat shock (HS; 40°C, 5--10 min; right panel). Samples for ChIP-seq analysis of RNAPII association were taken at 10 min in both experiments. (**B, C**) Genome browser tracks showing RNAPII ChIP-Seq read counts for the experiments described in (**A**) on a region on chromosome X containing three consecutive RP genes (in green, **B**) or at the *SSA1* gene on chromosome I (in red, **C**). Cells were either mock pre-treated (vehicle; left panels) or cycloheximide pre-treated (CHX; right panels) before heat shock (HS). Gene annotations (gene name, open-reading frame and direction of transcription) are shown above the tracks.](elife-45002-fig7){#fig7}

Discussion {#s3}
==========

In this study, we demonstrate the existence of a regulatory mechanism, which we refer to as the ribosome assembly stress response, or RASTR, that allows yeast cells to specifically coordinate the activity of two TFs, Hsf1 and Ifh1, with the functional state of ribosome assembly. Our data and several previous reports suggest that rapid ribosome biogenesis is a potentially proteotoxic process, in large part due to accumulation of unassembled RPs, whose production needs to be carefully coordinated at the transcriptional level, at least in yeast, together with that of chaperones and proteasome components ([Figure 8](#fig8){ref-type="fig"}). In this perspective, RASTR may play an essential role in minimizing the proteostasis burden imposed by high ribosome production rates, particularly under fluctuating environmental conditions.

![RP and Hsf1 target genes are regulated as a function of unassembled RP levels in both growing and stressed cells.\
In rapidly growing, un-stressed cells, RNAPII initiation at RP and Hsf1 target genes is continuously adjusted according to the levels of un-assembled RPs (central sector). Under various stress conditions (including RASTR, heat shock, TORC1 inhibition, perhaps many others), levels of unassembled RPs increase dramatically, and RPs accumulate with nucleolar proteins, Ifh1 and chaperones in an insoluble nuclear or nucleolar fraction. This leads to the rapid upregulation of Hsf1 target genes (e.g. chaperones and proteasome components), presumably through Hsp70 titration, and to the coincident downregulation of RP genes, through Ifh1 sequestration (bottom left sector, 'RP excess'). Conversely, a decrease in RP production (as provoked here by cycloheximide treatment) will lead to an opposite transcriptional response (bottom right sector, 'RP depletion'). In summary, we propose that levels of unassembled nuclear RPs act to constantly adjust RP and Hsf1 target gene expression, allowing the cell to balance growth with protein homeostasis.](elife-45002-fig8){#fig8}

Our data indicate that disequilibrium at any step-in ribosome biogenesis (rRNA transcription, early or late rRNA processing or assembly) will lead to RASTR activation until the pool of unassembled RPs decreases. Consequently, proteasome inhibition ([@bib30]), dNTP depletion ([@bib20]), DNA damage ([@bib9]), nutrient and thermal stress ([@bib35]; [@bib65]), all of which are known to alter rRNA transcription or processing, or ribosome assembly (reviewed in [@bib26]), are likely to activate RASTR, as do the genetic perturbations at different step of ribosome assembly described here. Taken together with previous reports, our data thus point to a critical role for RASTR in the transcriptional networks regulating both growth and protein homeostasis.

It is important to note that RPs are among the most abundant ubiquitinylated proteins that accumulate in the nucleus of proteasome-deficient *S. cerevisiae* and human cells ([@bib61]; [@bib62]; [@bib33]; [@bib41]), suggesting that the synthesis of RPs and their assembly into ribosomes must be tightly coordinated with the cell's proteostasis capacity. Consistent with this view, we show here that induction of ribosome assembly stress is correlated with the rapid accumulation of RPs in a detergent-insoluble fraction and that blocking de novo RP production, either by anchoring away Ifh1 or treating cells with cycloheximide, diminishes or abolishes a key transcriptional consequence of RASTR, namely upregulation of Hsf1 target genes. Our observations thus strongly suggest that RP aggregates are an important activating signal for RASTR. Nevertheless, we and others ([@bib61]) detect a large number of additional proteins that accumulate in an insoluble fraction upon ribosome assembly stress, including many RiBi proteins (e.g. numerous rRNA helicases and processing factors), the RP gene activator Ifh1, and chaperones. At present, we do not know the precise molecular nature of these aggregates, which presumably accumulate in the nucleolar space, or even whether they represent a common structure. In any event, our data suggest that RP- and Ifh1-containing aggregates are highly dynamic since the promoter release of Ifh1 and activation of Hsf1 following Top1 degradation are rapidly reversed by Top2 compensation ([Figure 1](#fig1){ref-type="fig"}) and Ifh1 aggregates that appear in *tom1-*Δ cells quickly diminish following cycloheximide treatment ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). We imagine that this provides a strong selective advantage by allowing cells to rapidly recover from a transient disruption of ribosome biogenesis.

Accumulation of proteins in insoluble fractions or aggregates underlies numerous diseases, as well as aging ([@bib55]; [@bib66]). However, certain protein aggregates appear to be dynamic structures that contribute to cellular fitness by protecting the cell during stress ([@bib8]; [@bib14]; [@bib22]; [@bib27]; [@bib45]). For example, stress granules and P-bodies, two of the most intensively studied insoluble macromolecular aggregates, have emerged as important cytoplasmic regulators of gene expression by controlling the processing, sequestering and/or degradation of specific RNA transcripts ([@bib13]; [@bib40]). Interestingly, it has recently been reported that nucleolar proteins can form sub-compartmental structures by promoting liquid-liquid phase separation ([@bib3]; [@bib16]). Although further work will be required to characterize the composition, assembly and function of these nucleolar membrane-less structures, they are attractive candidates for regulatory hubs that could act by sensing ribosome biogenesis stress and controlling adaptive responses. With respect to the present study, we imagine that liquid phase-separated structures in the nucleolus could be directly involved in sequestration of Ifh1 during RASTR, as well as the titration of Hsp70 that we propose leads to Hsf1 activation. A challenge for future studies will be to characterize the physical properties of these postulated structures and their relevance to the transcriptional outputs that we measure here.

We showed previously ([@bib1]) that in strains where RNAPI is constitutively active ([@bib32]) Ifh1 is released from RP gene promoters shortly after TORC1 inhibition by rapamycin treatment (\~5 min) but returns only 15 min later. This promoter re-binding does not occur in wild-type cells due to the action of two RiBi proteins (Utp22 and Rrp7) that can sequester Ifh1 in the CURI (Casein Kinase 2/Utp22/Rrp7/Ifh1) complex ([@bib1]; [@bib54]) allowing to re-align RP gene expression with RNAPI activity. These findings revealed that *S. cerevisiae* has developed temporally distinct mechanisms to regulate RP gene expression. One of the keys finding in the present study is to confirm the existence of a two-step process in RP gene regulation and to link the first step to control of the Hsf1 regulon. We propose that this short timescale mechanism results from a rapid rise in unassembled RPs that occurs immediately following TORC1 inhibition, or other stresses that disrupt ribosome assembly, such as depletion of Top1 or RiBi factors.

Following ribosome assembly stress, we imagine that the rapid induction of Hsf1 target genes, in combination with the arrest of RP gene transcription, contributes to the eventual clearing of proteotoxic unassembled RPs from the nucleus, thereby removing the signal that promotes RASTR and leads to Ifh1 promoter release and Hsf1 activation. Accordingly, RP production is abolished by 20 min following TORC1 inhibition ([@bib53]), suggesting that RASTR becomes inoperant, thus explaining the downregulation of Hsf1 genes ([Figure 6B](#fig6){ref-type="fig"}) and the switch to a secondary regulatory mechanism, involving sequestration of Ifh1 in the CURI complex, to align RP expression with rRNA production ([@bib1]). Consistent with this view, the short time scale mechanism of RP gene downregulation is abolished by attenuating proteotoxicity through translation inhibition (cycloheximide treatment) whereas the long time scale process is insensitive to translation arrest but can be prevented by expression of a constitutively active RNAPI ([@bib1]; [@bib32]). These two independent mechanisms adapt RP gene expression to both rRNA production and ribosome assembly, thus minimizing the accumulation of unassembled RPs.

As alluded to above, ribosome assembly stress in higher eukaryotes has been studied extensively in the context of ribosomopathies, diseases often associated with RP gene haplo-insufficiencies, RP gene point mutations or mutations in RiBi factors. One hypothesis put forward to explain these observations is that unassembled RPs trigger a feedback mechanism that decreases transcription of ribosome biogenesis genes by inhibiting c-Myc function and arrests cell growth through p53 activation ([@bib10]; [@bib36]). It has also been recently reported that the rRNA helicase DDX21 binds to and activates RP gene promoters in a manner that may be sensitive to the status of ribosome biogenesis ([@bib7]). Taken together, these findings suggest that unassembled RPs could mediate an ancestral process to regulate ribosome biogenesis conserved from prokaryotes ([@bib49]) to eukaryotes. Transcriptome analysis immediately following ribosome assembly stress in mammalian cells will be required to understand the interplay between these different mechanisms and may also uncover novel pathways.

Our work also provides insights into the connection between ribosome assembly and Hsf1 that was first revealed in a report from the Churchman lab that appeared as our work was being prepared for publication ([@bib67]). Hsf1 is a key sensor of proteotoxic stress in all eukaryotes that controls a common set of chaperones conserved from yeast to human. One protective function reported for Hsf1 is its ability to reduce protein aggregate formation leading to neurogenerative diseases ([@bib47]). On the other hand, Hsf1 also exerts a pro-oncogenic function through its ability to promote proteostasis in rapidly growing tumor cells ([@bib42]; [@bib56]). Despite its central function, a holistic understanding of the regulatory mechanisms that govern Hsf1 activity still missing. Our work and that of [@bib67] demonstrates that Hsf1 activity is tightly linked to ribosome biogenesis in yeast, in a manner independent of the previously described RQC mechanism that contributes to the dissociation of aberrant nascent polypeptides from the ribosome ([@bib4]). These two mechanisms highlight the central importance of ribosome assembly and activity in regulation of cellular protein homeostasis through Hsf1. Although it is currently unknown if RASTR is conserved in metazoans, we note that RPs are also subjected to a high turnover rate compared to other nuclear components in mammalian cells and that proteasome or ribosome assembly inhibition trigger a rapid accumulation of RPs in the nucleus, whereas arrest of translation has an opposite effect ([@bib61]; [@bib33]). Importantly, it was reported that cycloheximide treatment also abolishes Hsf1 activity in mammalian cell by an unknown mechanism ([@bib57]). We propose that a dynamic balance between unassembled and assembled RPs could be sensed by Hsf1 to constantly adjust protein homeostasis transcription programs in eukaryotes with translational flux, proteolysis and the rate of ribosome assembly ([Figure 8](#fig8){ref-type="fig"}), since disruption or hyperactivation of any of these processes will rapidly change nuclear levels of free RPs. Given the growing body of evidence linking Hsf1 activity to numerous diseases associated with proteotoxic stress, but also rapid cell growth in cancer, it will be of great interest to challenge this model in the future.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type                  Designation                                              Source or\                                                                      Identifiers                                                                                                                          Additional\
                                                                                         reference                                                                                                                                                                                                            information
  ----------------------------- -------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------
  Chemical compound, drug       Cycloheximide                                            Sigma                                                                           C7698                                                                                                                                Materials and methods subsection: Yeast strains and growth

  Chemical compound, drug       Rapamycin                                                Sigma                                                                           R8781                                                                                                                                Materials and methods subsection: Yeast strains and growth

  Chemical compound, drug       Auxin                                                    Sigma                                                                           1288G                                                                                                                                Materials and methods subsection: Yeast strains and growth

  Chemical compound, drug       Diazaborine                                              Provided by\                                                                    PMID: [29294095](https://www.ncbi.nlm.nih.gov/pubmed/29294095)                                                                       Materials and methods subsection: Yeast strains and growth
                                                                                         H Bergler. Zisser et al., 2018                                                                                                                                                                                       

  Commercial assay or kit       TruSeq ChIP Sample Preparation Kit                       Illumina                                                                        IP-202-9001DOC                                                                                                                       

  Antibody, rabbit polyclonal   Anti-RNA polymerase II CTD repeat YSPTSPS (phospho S5)   Abcam                                                                           ab5131                                                                                                                               Rabbit polyclonal; (1 ug per ChIP (50 ml OD = O0.5)

  Antibody, rabbit polyclonal   Anti-Rap1                                                N/A [@bib58]\                                                                   RRID: [AB_2801428](https://scicrunch.org/resolver/AB_2801428)                                                                        Rabbit polyclonal; (5 ul per ChIP (50 ml OD = O0.5)
                                                                                         (PMID:[15616569](https://www.ncbi.nlm.nih.gov/pubmed/15616569))                                                                                                                                                      

  Antibody                      Anti-Rpl3                                                Provided by [@bib68].                                                           PMID: [9121443](https://www.ncbi.nlm.nih.gov/pubmed/9121443)                                                                         Results, [Figure 5](#fig5){ref-type="fig"}. Mouse monoclonal; 1:10 000

  Antibody                      Anti-Rpl6                                                Provided by O Gadal                                                                                                                                                                                                  Rabbit polyclonal; 1:10 000

  Antibody                      Anti-Rps8                                                Provided by G Dieci                                                                                                                                                                                                  Rabbit polyclonal; 1:10 000

  Antibody, rabbit polyclonal   antibody Ifh1                                            N/A ([@bib28]) PMID: [25085421](https://www.ncbi.nlm.nih.gov/pubmed/25085421)   AB_2801429                                                                                                                           Rabbit polyclonal (2 ul per ChIP (50 ml OD = O0.5)

  Antibody, rabbit polyclonal   Antibody Fhl1                                            N/A ([@bib28]) PMID: [25085421](https://www.ncbi.nlm.nih.gov/pubmed/25085421)   AB_2801431                                                                                                                           Rabbit polyclonal (2 ul per ChIP (50 ml OD = O0.5)

  Strain, strain background     *Saccharomyces cerevisiae*, W303                         W303: *MAT***a**/*MAT*α *leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15*   Thomas & Rothstein, 1989. PMID: [2645056](https://www.ncbi.nlm.nih.gov/pubmed/2645056). Experimental procedures, Strains. Table 1.   See [Supplementary file 7](#supp7){ref-type="supplementary-material"}

  Other                         Primary sequence files                                   GEO                                                                             accession number GSE125226                                                                                                           Materials and methods subsection: Plasmid construction

  Recombinant DNA reagent       pFA6a-link-GFPEnvy-SpHis5 (plasmid)                      Addgene                                                                         RRID: [Addgene_60782](https://scicrunch.org/resolver/Addgene_60782)                                                                  Materials and methods subsection: Plasmid construction

  Recombinant DNA reagent       RPL25-envyGFP-plasmid                                    This paper                                                                      Plasmid \#1037                                                                                                                       Materials and methods\
                                                                                                                                                                                                                                                                                                              subsection: Plasmid construction

  Recombinant DNA reagent       pRS315-RPL25-eGFP                                        [@bib43] PMID: [11313466](https://www.ncbi.nlm.nih.gov/pubmed/11313466)                                                                                                                                              Materials and methods\
                                                                                                                                                                                                                                                                                                              subsection: Plasmid constructions
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ChIP-Seq {#s4-1}
--------

Cultures of 50 mL in YPAD were collected at OD~600~0.4--0.8 for each condition. The cells were crosslinked with 1% formaldehyde for 5 min at room temperature and quenched by adding 125 mM glycine for 5 min at room temperature. Cells were washed with ice-cold HBS and resuspended in 3.6 mL of ChIP lysis buffer (50 mM HEPES-Na pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% sodium deoxycholate) supplemented with 1 mM PMSF and 1x protease inhibitor cocktail (Roche). Samples were aliquoted in Eppendorf tubes and frozen. After thawing, the cells were broken using Zirconia/Silica beads (BioSpec). The lysate was spun at 13,000 rpm for 30 min at 4°C and the pellet was resuspended in 300 μl ChIP lysis buffer + 1 mM PMSF and sonicated for 15 min (30 s ON - 60 s OFF) in a Bioruptor (Diagenode). The lysate was spun at 7000 rpm for 15 min at 4°C. Antibody (1 μg / 300 μL of lysate, Abcam ab5131) was added to the supernatant and incubated for 1 hr at 4°C. Magnetic beads were washed three times with PBS plus 0.5% BSA and added to the lysates (30 μL of beads/300 μL of lysate). The samples were incubated for 2 hr at 4°C. The beads were washed twice with (50 mM HEPES-Na pH 7.5, 140 mM NaCl, 1 mM EDTA, 0.03% SDS), once with AT2 buffer (50 mM HEPES-Na pH 7.5, 1 M NaCl, 1 mM EDTA), once with AT3 buffer (20 mM Tris-Cl pH 7.5, 250 mM LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate) and twice with TE. The chromatin was eluted from the beads by resuspension in TE + 1% SDS and incubation at 65°C for 10 min. The eluate was transferred to an Eppendorf tube and incubated overnight at 65°C to reverse the crosslinks. The DNA was purified using High Pure PCR Cleanup Micro Kit (Roche). DNA libraries were prepared using TruSeq ChIP Sample Preparation Kit (Illumina) according to manufacturer's instructions. The libraries were sequenced using an Illumina HiSeq 2500 and the reads were mapped to the sacCer3 genome assembly using HTSStation (shift = 150 bp, extension = 50 bp; [@bib12]). To compare depleted versus non-depleted cells, we divided the signal from the + auxin and/or rapamycin and/or cycloheximide samples by the signal from the -- auxin and/or rapamycin and/or cycloheximide (vehicle) samples and log2 transformed this value. All data from publicly available databases were mapped using HTS Station (<http://htsstation.epfl.ch>; [@bib12]).

Yeast strains, primer DNAs and cell growth {#s4-2}
------------------------------------------

Strains used in this study are listed in [Supplementary file 7](#supp7){ref-type="supplementary-material"}. For ChIP-qPCR, the primer sequences used a listed in [Supplementary file 8](#supp8){ref-type="supplementary-material"}. Experiments were typically performed with log phase cells harvested between OD~600~ 0.4 and 0.8. Anchor-away of FRB-tagged proteins was induced by the addition of rapamycin (1 mg/ml of 90% ethanol/10% Tween stock solution) to a final concentration of 1 μg/ml ([@bib24]). Depletion of AID-tagged protein was induced by the addition of auxin (3-indoloacetic acid) at 500 μM final concentration. Arrest of translation was induced by the addition of cycloheximide to a final concentration of 25 μg/ml. Cells are treated with diazaborine to a final concentration of 50 ug/ml.

Fluorescence microscopy {#s4-3}
-----------------------

Cells were grown overnight at 30°C in SC medium (0.67% nitrogen base without amino acids (BD), 2% dextrose supplemented with amino acids mixture (AA mixture; Bio101), adenine, and uracil). Cells were diluted and were harvested when OD~600~ reached 0.4. Cells were spread on slides coated with an SC medium patch containing 2% glucose. Stacked images were recorded (Intelligent Imaging Innovations) at a spinning disc confocal inverted microscope (Leica DMIRE2) using the 100x oil objective and an Evolve EMCCD Camera (Photometrics).

Insoluble fraction purification and mass spectrometry {#s4-4}
-----------------------------------------------------

Isolation of protein aggregates from yeast cells was performed as described previously ([@bib29]) with slight modifications. 50 OD~600~ units (50 ml) of exponentially growing cells were harvested, and cell pellets were frozen in liquid N2. The cell pellets were resuspended in 1 ml lysis buffer (20 mM Na-phosphate pH 6.8, 10 mM DTT, 1 mM EDTA, 0.1% Tween, 1 mM PMSF, protease inhibitor cocktail and 100 units/ml zymolyase) and incubated at 30° C for 30 min. Chilled samples were treated by tip sonication (20%, 10 s, 2x) and centrifuged for 20 min at 600 g at 4°C. Aggregated proteins were pelleted at 16,000 g for 20 min at 4°C. After removing supernatants, insoluble proteins were washed once with Wash I buffer (20 mM Na-phosphate pH 6.8, 500 mM NaCl, 5 mM EDTA, 2% NP-40, 1 mM PMSF, and protease inhibitor cocktail), and centrifuged at 16,000 g for 20 min at 4°C. Insoluble proteins were washed with Wash II buffer (20 mM Na-phosphate pH 6.8, ice-cold), pelleted and sonicated (2x for 10 s) in 40 μl of Wash II buffer. For analysis by SDS-PAGE (4--12% acrylamide) and subsequent western blotting, proteins were first boiled in Laemmli buffer. 1x of the total cell lysate and 25x of the insoluble pellet fraction were separated and analyzed by Coomassie Blue staining or immunoblotting. Proteins were identified by shotgun mass spectrometry analysis at the Functional Genomics Center Zurich (ETH, Zurich) following TCA precipitation (20%) and acetone washing, according to posted procedures. Database searches were performed by using the Mascot (SwissProt, all species; SwissProt, yeast) search program, using very stringent settings in Scaffold (1% protein FDR, a minimum of 2 peptides per protein, 0.1% peptide FDR).

Polysome gradients {#s4-5}
------------------

Yeast cells growing exponentially were treated or not with auxin for 20 min. 50 µg/mL cycloheximide (Sigma) was added directly to the culture medium. Cells were collected by centrifugation, rinsed with buffer K \[20 mM Tris-HCl pH 7.4, 50 mM KCl, 10 mM MgCl~2~\] supplemented with 50 µg/mL cycloheximide and collected again by centrifugation. Dry pellets were resuspended with approximately one volume of ice-cold buffer K supplemented with 1 mM DTT, 1 × Complete EDTA-free protease inhibitor cocktail (Roche), 0.1 U/µL RNasin (Promega) and 50 µg/mL cycloheximide. About 250 µL of ice-cold glass beads (Sigma) were added to 500 µL aliquots of the resuspended cells and cells were broken by vigorous shaking, three times 2 min, separated by 2 min incubations on ice. Extracts were clarified through two successive centrifugations at 13,000 rpm and 4°C for 5 min and quantified by measuring absorbance at 260 nm. About 30 A~260~ units were loaded onto 10--50% sucrose gradients in buffer K, and then centrifuged for 150 min at 39,000 rpm and 4°C in an Optima L-100XP Ultracentrifuge (Beckman-Coulter) using a SW41Ti rotor without brake. Following centrifugation, 18 fractions of 500 µl each were collected from the top of the gradients with a Foxy Jr. apparatus (Teledyne ISCO). The absorbance at 254 nm was measured during collection with a UA-6 device (Teledyne ISCO).

Pulse labeling, RNA extraction and Northern hybridization {#s4-6}
---------------------------------------------------------

Metabolic labeling of pre-rRNAs was performed as previously described ([@bib64]) with the following modifications. Strains were grown in synthetic glucose medium lacking adenine to an OD~600~ of 0.8. Auxin (0.5 mM) was next added to the cultures and cells were labeled for 2 min with \[2,8-^3^H\]-adenine (NET06300 Perkin Elmer) at 0, 10, 20 and 30 min following the addition of auxin. Cell pellets were frozen in liquid nitrogen. RNA extractions and Northern hybridizations were performed as previously described ([@bib2]). For high-molecular-weight RNA analysis, 2 μg of total RNA were glyoxal denatured and resolved on a 1.2% agarose gel. Note that Northern hybridization was performed on \[2,8-^3^H\]-adenine labeled RNA. The membrane was first exposed to reveal neo-synthetized transcripts, and subsequent Northern hybridization revealed rRNA transcript abundance.

Data availability {#s4-7}
-----------------

Read counts for all RNAPII ChIP-seq experiments (integrated counts over the complete open reading frame of all protein-coding genes) are given in [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[6](#supp6){ref-type="supplementary-material"}. Primary processed sequence files will be made available at Gene Expression Omnibus (GEO accession number GSE125226).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A ribosome assembly stress response regulates transcription to maintain proteome homeostasis\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Naama Barkai as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: John Woolford (Reviewer \#2); Marlene Oeffinger (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This report shows that depletion of Top1, which leads to arrest of Pol I elongation, evokes a specific induction of the Hsf1 regulon, and not the general ESR, which can be blocked by anchor away of Hsf1; and also evokes the rapid downregulation of nearly all ribosome protein genes (RPGs), which can be attributed to loss of the transcription factor Ifh1 from RPG promoters. They term this response RASTR for Ribosome Assembly Stress Response. Evidence is presented that the signal for both responses, Hsf1 target induction and RPG repression, is a defect in 60S ribosome biogenesis associated with accumulation of nuclear aggregates of unassembled RPs, which sequester Ifh1 from RPG promoters. They show that blocking new synthesis of RPs by anchor away of Ifh1 blocks induction of Hsf1 targets on depletion of Top1. Moreover, they show that cycloheximide (CHX) treatment blocks both aspects of RASTR, presumably by preventing accumulation of newly synthesized RPs in nuclear aggregates capable of sequestering Ifh1, (although this effect of CHX on aggregation of RPs and Ifh1 was not directly demonstrated). CHX also appears to block the RASTR that is triggered immediately by Rapamycin presumably owing to an immediate inhibition of rRNA processing before the onset of RP repression, leading to accumulation of RP aggregates that sequester Ifh1. However, again, this interpretation was not supported by direct evidence of nuclear aggregates of RPs and Ifh1 at early, but not later, times of Rapamycin treatment, which are eliminated by CHX treatment. The authors conclude that unassembled RPs in nuclear aggregates serve to activate the Hsf1 regulon and down-regulate RPG transcription by sequestering Ifh1 as a means of tightly regulating RP expression and responding to the toxicity of RP aggregates, which functions both in normal cells and during conditions of unbalanced RP and rRNA production when ribosome biogenesis is impaired, when TORC1 is acutely inhibited by Rapamycin, and during heat-shock.

Essential revisions:

Additional experiments are required to establish that the accumulation of ribosomal proteins and Ifh1 in nuclear aggregates is diminished in cells treated with cycloheximide (CHX) to justify the interpretations of multiple experiments in Figures 5-6, in which CHX is found to block RASTR in response to Top1 depletion or at the early time points of rapamycin treatment. The authors should also confirm that Ifh1 promoter occupancy is reduced in tom1 cells to bolster their interpretation of the genetic data in Figure 3D. Revisions of text are also needed throughout the paper to better explain the rationale behind certain experiments or their design, and to expand the Discussion to consider the signals for triggering RASTR (does it involve unassembled 40S proteins, is it limited to the early stages of ribosome assembly), the conditions that lead to cessation of the response, and situations in WT cells in which it would be triggered (all described in the major comments of reviewer \#2 and \#3).

Reviewer \#1:

This report shows that depletion of Top1, which leads to arrest of Pol I elongation evokes a specific induction of the Hsf1 regulon, and not the general ESR, which is blocked by anchor away of Hsf1; and also to rapid downregulation of nearly all ribosome protein genes (RPGs), which can be attributed to loss of the transcription factor Ifh1 from RPG promoters. They term this response RASTR for Ribosome Assembly Stress Response. Evidence is presented that the signal for both responses, Hsf1 target induction and RPG repression, is a defect in 60S ribosome biogenesis associated with accumulation of nuclear aggregates of unassembled RPs, which sequester Ifh1 from RPG promoters. Unlike in cells treated with Rapamycin, in which Ifh1 also is sequestered, the removal of Ifh1 from RPG promoters in RASTR does not required the Ifh1 C-terminal domain. They show that blocking new synthesis of RPs by anchor away of Ifh1 blocks induction of Hsf1 targets on depletion of Top1. Moreover, they show that cycloheximide (CHX) treatment blocks both aspects of RASTR, presumably by preventing accumulation of newly synthesized RPs in nuclear aggregates capable of sequestering Ifh1, although this effect of CHX on aggregation of RPs and Ifh1 is not directly demonstrated. CHX also appears to block the RASTR that is triggered immediately by Rapamycin presumably owing to an immediate inhibition of rRNA processing before the onset of RP repression, leading to accumulation of RP aggregates that sequester Ifh1. However, again, this interpretation was not supported by direct evidence of nuclear aggregates of RPs and Ifh1 at early, but not later, times of Rapamycin treatment, which are eliminated by CHX treatment. The authors conclude that unassembled RPs in nuclear aggregates serve to activate the Hsf1 regulon and down-regulate RPG transcription by sequestering Ifh1 as a means of tightly regulating RP expression and responding to the toxicity of RP aggregates, which functions both in normal cells and during conditions of unbalanced RP and rRNA production when ribosome biogenesis is impaired, TORC1 is acutely inhibited by Rapamycin, and in heat-shock.

The findings in this paper are significant in showing specific induction of the Hsf1 regulon, and not the general ESR, when ribosome biogenesis is impaired either by depleting Top1, known already and confirmed here to arrest Pol I elongation, or by interfering with 60S biogenesis in different ways; and in describing a mechanism for the concurrent reduction in RP transcription via sequestration of Ifh1 in nuclear aggregates of unassembled ribosomal proteins.

\- It was felt that direct evidence is needed that the accumulation of RPs and Ifh1 in nuclear aggregates is diminished in cells treated with cycloheximide (CHX) to justify their interpretations of the multiple experiments in Figures 5-6 in which CHX is found to block the RASTR in response to Top1 depletion or at the early time points of rapamycin treatment.

\- The authors should also show that Ifh1 promoter occupancy is reduced in tom1 cells to bolster their interpretation of the genetic data in Figure 3D.

Reviewer \#2:

This is an interesting and timely manuscript describing discovery of the so-called Ribosome Assembly Stress Response (RASTR) pathway: When ribosome assembly is blocked, transcription by Hsf1 to activate protein homeostasis genes (encoding chaperones, aggregates, and proteasomal proteins) is upregulated, and ribosomal protein gene transcription is down-regulated. Further experiments explain how this occurs. When ribosome assembly is blocked by aborting rRNA transcription or preventing assembly factor function, excess unassembled ribosomal proteins aggregate. This leads to sequestration of Hsp70, an inhibitor of Hsf1, as well as Ifh, which is necessary for transcription of RP genes.

The RASTR mediated pathway is rapid and apparently short-lived, activated within 5 minor aborting assembly, but returning to previous levels of expression of r protein proteostasis genes within an hour. It is not yet known whether r proteins, Ifh1, and Hsp70 are present in separate pools of aggregates, or whether or how they traffic into or out of aggregates.

Because ribosomal proteins are synthesized at such high levels in rapidly growing cells, RASTR represents a significant mechanism to prevent proteostasis when assembly is imbalanced by any means.

Some data are presented to distinguish RASTR from other stress response pathways, and to distinguish long term responses from the short term RASTR pathway. I found this portion of the Results and Discussion difficult to follow at times. The manuscript could perhaps be made more clear, especially for a general readership, by including a short paragraph early in the Discussion clearly outlining in one place the different pathways. To what exactly might each pathway respond and why? For example, what are general means by which imbalance in synthesis of ribosome components could be created in wild type cells (or by mutation?) and what then enables a return to normal synthesis once RASTR is inactivated? Is it diminished pools of aggregates? Then what about the primary triggers for the pathway? It also might be worth repeating here exactly where and how the CURI complex fits in to these effects.

Reviewer \#3:

In the submitted manuscript by Albert et al., the authors identify the Ribosomal Assembly Stress Response (RASTR), a novel regulatory pathway that responds to excess numbers of RPs and their aggregation, and allows a simultaneous up-regulation of protein homeostasis genes and down-regulation of RP genes upon disruption of ribosome biogenesis at different stages, providing a mechanism for the cell to counteract RP proteotoxicity.

Overall, the data presented here is very interesting and experimentally sound. The data is mostly well-presented and the manuscript generally concise; however, a few points should be addressed by the authors.

\- Throughout, the authors focus on the accumulation and fate of large subunit RPs and in Figure 2C and D, only large subunit RPs are shown by western blot. Have the authors looked at small subunit RPs? Given that the stresses shown here affect pre-rRNA transcription and assembly of RPs with pre-rRNA is co-transcriptional, the sRPs should also be affected and involved in the RASTR. The authors should address this point in their Discussion at the very least.

\- The authors selected Utp8 and Utp13 to mimic a ribosome assembly stress response as observed with Top1 and Top1/2 deletion; why were these two proteins chosen specifically? This should be explained for an audience less familiar with ribosome biogenesis.

\- Along these lines, the authors say that disruption of ribosome biogenesis at several levels -- pre-rRNA transcription/processing, assembly -- will activate RASTR. What about later stages in assembly/processing than the one tested in the 90S complex? Is the response related to early RiBi pathways steps?

\- Figure 2---figure supplement 1D: tae2-Δ cells -- the figure/experiment described in the text does not match the panel/legend -- please make sure it is the correct data panel or labeled to be made clearer to the reader.

\- While the manuscript and the logic of experiments is in most cases obvious to a reader within the immediate field, it may be less so to a general/non-ribosome biogenesis readership. I would suggest the authors be more liberal and expansive with some of their explanations, one example being the choice of Utp8 and Utp13, but there are others throughout.

\- Figure 2A: labels for the northern probe(s) used should be added as well as labels for the precursors visualized.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"A ribosome assembly stress response regulates transcription to maintain proteome homeostasis\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Naama Barkai as the Senior Editor and a Reviewing Editor.

The manuscript has been improved substantially but there are a few remaining issues that need to be addressed before acceptance, as outlined below:

1\) The new experiment presented in Figure 3D lacks the WT TOM1 control strain needed to establish that the Ifh1 foci occur only in the tom1 mutant cells.

2\) It appears that the data are mislabeled in the new Figure 5---figure supplement 1E-F.

3\) Please re-proof all new figures and revised text for correctness.

10.7554/eLife.45002.029

Author response

> Reviewer \#1:
>
> \[...\] -- It was felt that direct evidence is needed that the accumulation of RPs and Ifh1 in nuclear aggregates is diminished in cells treated with cycloheximide (CHX) to justify their interpretations of the multiple experiments in Figures 5-6 in which CHX is found to block the RASTR in response to Top1 depletion or at the early time points of rapamycin treatment.

We agree with the reviewer that these data are important for interpretation of the experiments shown in Figures 5 and 6. To address this issue, we first point out more clearly in the revised text that the Deshaies lab (Sung et al., 2016) have already shown by MS analysis that RP aggregation following proteasome inhibition is strongly diminished upon cycloheximide (CHX) addition. Since the aggregation assay that they used didn't allow them to discriminate between cytosolic and nuclear aggregates we decided to use an alternative approach (live cell imaging) to observe accumulation of RPs and Ifh1 in protein aggregates. To this end, we expressed Super-Fold GFP-tagged versions of Ifh1 and Rpl25 and observed their aggregation (foci formation) in the presence or absence of CHX. Significantly, we found that Ifh1 forms small punctate structures in a *tom1-Δ* strain (new Figure 3D). Remarkably, these nuclear structures rapidly diminish (20 min) after CHX treatment (new Figure 5---figure supplement 1B). Furthermore, we have now added data showing that the accumulation of Ifh1 in nuclear aggregates observed during RASTR (old Figure 3C) is abolished in the presence of cycloheximide (CHX) (new Figure 5G),in agreement with the proposed model, now in Figure 8. Lastly, we observed during RASTR activation that Rpl25-eGFP rapidly forms a nuclear structure that is not observed in the presence of CHX (new Figure 5F). Taken together, we believe that our new results provide very clear evidence that CHX blocks (or strongly diminishes) the formation of both RP and Ifh1 aggregates following RASTR activation.

> \- The authors should also show that Ifh1 promoter occupancy is reduced in tom1 cells to bolster their interpretation of the genetic data in Figure 3D.

As suggested by the reviewer, we performed Ifh1 ChIP in *tom1-*Δ cells, which showed that Ifh1 binding at *RPL30* appears to be reduced compared to that in *TOM1* cells (new Figure 5---figure supplement 1C). However, this reduction is small, and we are hesitant to place too much weight on quantitative comparisons of ChIP enrichment in different strains. Nevertheless, this small difference in Ifh1 binding is in agreement with the near wild-type growth rate of the *tom1-Δ* strain, suggesting that the level of Ifh1 promoter occupancy in *tom1-Δ* remains sufficient to promote near normal RP gene transcription. Importantly, though, cycloheximide treatment triggers a significant increase in Ifh1 promoter binding in *tom1-Δ* strains compared to wild type (new Figure 5---figure supplement 1C), consistent with the disappearance of Ifh1 nuclear aggregates upon CHX treatment in the *tom1-Δ* strain (new Figure 5---figure supplement 1B). These data support the idea that *tom1-Δ* does indeed increase the amount of Ifh1 trapped in an insoluble nuclear fraction that can be rapidly released upon CHX treatment to increase binding at RP promoters.

Lastly, to exclude the possibility that the genetic interaction between *TOM1* and the hypo-morphic *ifh1-AA* allele (shown previously in Figure 3D) could be linked to the growth defect of this mutation, we examined another mutated allele of *IFH1 (ifh1-6*) that triggers a similar growth defect (new Figure 3E).

Importantly, the ifh1-6 mutant protein remains bound at high levels to RP gene promoters even under stress conditions, whereas ifh1-AA interacts weakly with RP gene promoters, even under optimal growth conditions (Albert et al., 2016). Remarkably, *tom1-Δ* is synthetically lethal only with ifh1-AA (new Figure 3E), supporting the notion that this genetic interaction is directly linked to the ability of Ifh1 to bind RP gene promoters. Altogether, we believe that these data strongly support the idea that one part of the pool of Ifh1 is trapped in an insoluble nuclear fraction in absence of Tom1 and prevented from binding to RP gene promoters.

> Reviewer \#2:
>
> This is an interesting and timely manuscript describing discovery of the so-called Ribosome Assembly Stress Response (RASTR) pathway: When ribosome assembly is blocked, transcription by Hsf1 to activate protein homeostasis genes (encoding chaperones, aggregates, and proteasomal proteins) is upregulated, and ribosomal protein gene transcription is down-regulated. Further experiments explain how this occurs. When ribosome assembly is blocked by aborting rRNA transcription or preventing assembly factor function, excess unassembled ribosomal proteins aggregate. This leads to sequestration of Hsp70, an inhibitor of Hsf1, as well as Ifh, which is necessary for transcription of RP genes.
>
> The RASTR mediated pathway is rapid and apparently short-lived, activated within 5 minor aborting assembly, but returning to previous levels of expression of r protein proteostasis genes within an hour. It is not yet known whether r proteins, Ifh1, and Hsp70 are present in separate pools of aggregates, or whether or how they traffic into or out of aggregates.
>
> Because ribosomal proteins are synthesized at such high levels in rapidly growing cells, RASTR represents a significant mechanism to prevent proteostasis when assembly is imbalanced by any means.
>
> Some data are presented to distinguish RASTR from other stress response pathways, and to distinguish long term responses from the short term RASTR pathway. I found this portion of the Results and Discussion difficult to follow at times. The manuscript could perhaps be made more clear, especially for a general readership, by including a short paragraph early in the Discussion clearly outlining in one place the different pathways. To what exactly might each pathway respond and why? For example, what are general means by which imbalance in synthesis of ribosome components could be created in wild type cells (or by mutation?).

These are excellent questions, and we agree that the original manuscript was overly concise, to the point where even well-informed general readers might have difficulty following the arguments. To improve clarity, we have expanded both the Discussion and Introduction, emphasizing more the identity and role of the CURI complex in balancing rRNA and RP production at extended periods following stress (TORC1 inhibition) and pointing out that RASTR is a mechanistically distinct and faster acting response. We also include speculation regarding the physiological and genetic perturbations that might activate these two different responses.

> What then enables a return to normal synthesis once RASTR is inactivated? Is it diminished pools of aggregates?

As pointed out above, our new data strongly suggest that the return to normal RP and Hsf1 target gene expression is promoted by the diminution of pools of aggregates, of both Ifh1 and RPs. This is now clearly stated in the text.

> Then what about the primary triggers for the pathway? It also might be worth repeating here exactly where and how the CURI complex fits in to these effects.

This is a good point. We add speculation in the Discussion to the effect that the long-term regulation through the CURI complex may be driven by the release of its two rRNA processing components, Utp22 and Rrp7 from nascent rDNA, freeing them for interaction with Ifh1.

> Reviewer \#3:
>
> In the submitted manuscript by Albert et al., the authors identify the Ribosomal Assembly Stress Response (RASTR), a novel regulatory pathway that responds to excess numbers of RPs and their aggregation, and allows a simultaneous up-regulation of protein homeostasis genes and down-regulation of RP genes upon disruption of ribosome biogenesis at different stages, providing a mechanism for the cell to counteract RP proteotoxicity.
>
> Overall, the data presented here is very interesting and experimentally sound. The data is mostly well-presented and the manuscript generally concise; however, a few points should be addressed by the authors.
>
> \- Throughout, the authors focus on the accumulation and fate of large subunit RPs and in Figure 2C and D, only large subunit RPs are shown by western blot. Have the authors looked at small subunit RPs? Given that the stresses shown here affect pre-rRNA transcription and assembly of RPs with pre-rRNA is co-transcriptional, the sRPs should also be affected and involved in the RASTR. The authors should address this point in their Discussion at the very least.

This is a good point, and we agree that sRPs should be affected by and involved in RASTR. Consistent with this, we detect by mass spectrometry both large and small subunit RPs (43 Rpl and 30 Rps proteins) in the insoluble fraction following topoisomerases depletion (new Figure 3---figure supplement 1B) and we detect accumulation of a small subunit protein, Rps8, in trailing fractions of polysome gradients (new Figure 2C). We thank the reviewer for pointing this out.

> \- The authors selected Utp8 and Utp13 to mimic a ribosome assembly stress response as observed with Top1 and Top1/2 deletion; why were these two proteins chosen specifically? This should be explained for an audience less familiar with ribosome biogenesis.

We agree with the reviewer. We now explain in the revised text why these factors were selected. Please see our reply to comment \#4 of the reviewer \#2.

> \- Along these lines, the authors say that disruption of ribosome biogenesis at several levels -- pre-rRNA transcription/processing, assembly -- will activate RASTR. What about later stages in assembly/processing than the one tested in the 90S complex? Is the response related to early RiBi pathways steps?

We agree with the reviewer that this is an important point. In the manuscript we show that diazaborine, an inhibitor acting at the mid-late steps of 60S biogenesis, activates RASTR, suggesting that this pathway is not limited to early steps. Nevertheless, it's important to note that blocking maturation of late cytoplasmic large subunit precursors results in a rapid depletion of early acting factors in the nucleolus due to trapping of these factors in the accumulating late populations (Zisser et al. \[2018\] *NAR* 46: 3140). The failure to recycle these proteins results in a rapid feedback at an early maturation step. We speculate that both early and late stages of assembly will rapidly activate RASTR but acknowledge that further work will be required to nail this down.

> \- Figure 2---figure supplement 1D: tae2-Δ cells -- the figure/experiment described in the text does not match the panel/legend -- please make sure it is the correct data panel or labeled to be made clearer to the reader.

We thank the reviewer for catching this mistake. The text and figure now describe Rpb1 ChIP of two Hsf1 target genes and two RP genes following Top1/2 degradation in a *tae2-*Δ background. The data (qPCR ChIP) show that both sets of genes respond as in *TAE2* wild-type cells, ruling out a role for RQC in RASTR (see new Figure 2---figure supplement 1D).

> \- While the manuscript and the logic of experiments is in most cases obvious to a reader within the immediate field, it may be less so to a general/non-ribosome biogenesis readership. I would suggest the authors be more liberal and expansive with some of their explanations, one example being the choice of Utp8 and Utp13, but there are others throughout.

We agree with the reviewer that the text is too concise and lacking in detail. We have extensively expanded the text to make both the experiments and their interpretation clearer.

> \- Figure 2A: labels for the northern probe(s) used should be added as well as labels for the precursors visualized.

We apologize for this omission. Please see reply to the comment \#1 of the reviewer \#2.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Thank you for resubmitting your work entitled \"A ribosome assembly stress response regulates transcription to maintain proteome homeostasis\" for further consideration at eLife. Your revised article has been favorably evaluated by Naama Barkai as the Senior Editor and a Reviewing Editor.
>
> The manuscript has been improved substantially but there are a few remaining issues that need to be addressed before acceptance, as outlined below:
>
> 1\) The new experiment presented in Figure 3D lacks the WT TOM1 control strain needed to establish that the Ifh1 foci occur only in the tom1 mutant cells.

We have now included the *TOM1* control in Figure 3D which establishes that Ifh1 does not form foci in wild-type cells. This was apparent from other images, but you're right that it's best to show the control directly in Figure 3D. Thanks for pointing this out.

> 2\) It appears that the data are mislabeled in the new Figure 5---figure supplement 1E-F.

You're absolutely right about the swapped labeling on Figure 5---figure supplement 1E-F, and we thank you for pointing out this mistake, which has now been corrected.

> 3\) Please re-proof all new figures and revised text for correctness.

Checking everything again we realized that there were graphical mistakes in the cartoons of Figures 1, 4 and 5. These have been corrected and we have uploaded the revised figures. The rest of the manuscript and figures have been checked and appear to us to be correct.
